Company intelligence / Profile preview

BIOptimizers

Ownership: Private
Development stage: Commercial

Overview

BIOptimizers has a portfolio of research-backed nutritional supplements focused on digestive health, gut microbiome optimization, stress management, sleep improvement, energy enhancement, and overall well-being. Their flagship products—MassZymes (digestive enzyme), P3–OM (probiotic), and Magnesium Breakthrough—are widely used by consumers seeking holistic wellness solutions. The company invests in R&D partnerships with academic institutions to advance probiotic science but does not conduct pharmaceutical clinical trials. No clinical trial data in the pharmaceutical sense; efficacy claims are based on consumer feedback and scientific literature supporting ingredient benefits.

Therapeutic areas: GastroenterologyImmunologyNeurologyOther
Modalities: Small molecule (vitamins, minerals)Protein (enzymes)Probiotic (live biotherapeutic product therapy)Herbal extract
Industry: Food & Nutrition

Drug pipeline

2 assets

Magnesium Breakthrough

Commercial

Indications: Magnesium deficiency, Sleep support, Stress management

1 more asset in the full pipeline.

Request access →

Partnerships

Burch University Sarajevo/Bosnia probiotics lab partnership

Beyond the preview

Go deeper on BIOptimizers.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BIOptimizers.

Explore the full profile